ArticleFrontiers in public health2022
Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Applications and outcomes of implementing telemedicine for hypertension management in COVID-19 pandemic: A systematic review.PloS one · 2024Pooled it
- Association between a clinical pharmacist-led multimodal remote medication intervention and individualized treatment outcomes in patients with type 2 diabetes mellitus.Frontiers in endocrinology · 2026Article
- Analysis of experiences on telemedicine pilot projects from the perspectives of doctors, pharmacists, and patients.The Korean journal of internal medicine · 2026Article
- Telemedicine in Korea: bridging the gap between convenience and clinical safety.The Korean journal of internal medicine · 2026Article
- A comprehensive global review on pharmacist-led strategies to support medication therapy in hypertensive patients.Journal of human hypertension · 2025Review
- Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease.NPJ digital medicine · 2025Article
- Pharmacist-Led Digital Health Interventions for Patients with Diabetes: A Systematic Review.Journal of multidisciplinary healthcare · 2025Review
- Utilization of telehealth services in low- and middle-income countries amid the COVID-19 pandemic: a narrative summary.Global health action · 2023Review
- Randomized Controlled Trial of Home Telemonitoring of Blood Pressure with an Adapted Tensiometer with SMS Capability.European journal of investigation in health, psychology and education · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate the impact of a telemedicine medication management service in patients with hypertension. Methods: Participants were allocated to either a telemedicine service ( Results: At 6 months, BP was controlled in 89.6% ( Conclusion: Telemedicine medication management for hypertension management had led to better BP control and medication adherence improvement than UC during COVID-19 epidemic, resulting in a reduction of overall adverse cardiovascular events occurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.